VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

BSC® Insights

BSC team publishes new article on Propensity Score Design

Insights

1 min read time

Congratulations to Brendan Keenan and Greg Maislin for their recent publication in Sleep Research Society! Fantastic job, Greg and Brendan!

In the article, they propose that Propensity Score designs are the optimal approach to address the impact of continuous positive airway pressure (CPAP) on cardiovascular events. Propensity Score Methodology is accepted by the FDA for medical devices and can provide an opportunity to robustly assess the cardiovascular benefit of CPAP in real-world patients and overcome biases in randomized clinical trials.

Interested in knowing more? Check this article here!

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.